BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27904778)

  • 21. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
    Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
    Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt/β-catenin pathway in epithelial ovarian carcinoma cells.
    Wang B; Liu M; Zhuang R; Jiang J; Gao J; Wang H; Chen H; Zhang Z; Kuang Y; Li P
    Oncol Lett; 2018 Mar; 15(3):3369-3375. PubMed ID: 29435081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA SNHG20 promotes gastric cancer progression by inhibiting p21 expression and regulating the GSK-3β/ β-catenin signaling pathway.
    Liu J; Liu L; Wan JX; Song Y
    Oncotarget; 2017 Oct; 8(46):80700-80708. PubMed ID: 29113337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of long non-coding RNA colon cancer-associated transcript 2 is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.
    Zhang J; Jiang Y; Zhu J; Wu T; Ma J; Du C; Chen S; Li T; Han J; Wang X
    Oncol Lett; 2017 Dec; 14(6):6907-6914. PubMed ID: 29181105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells.
    Li CH; Chen ZM; Chen PF; Meng L; Sui WN; Ying SC; Xu AM; Han WX
    World J Gastrointest Oncol; 2022 Oct; 14(10):1968-1980. PubMed ID: 36310707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of lncRNA HOXA11-AS promotes cell epithelial-mesenchymal transition by repressing miR-200b in non-small cell lung cancer.
    Chen JH; Zhou LY; Xu S; Zheng YL; Wan YF; Hu CP
    Cancer Cell Int; 2017; 17():64. PubMed ID: 28615992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA CARLo-5 promotes tumor progression in hepatocellular carcinoma via suppressing miR-200b expression.
    Dou C; Sun L; Jin X; Han M; Zhang B; Jiang X; Lv J; Li T
    Oncotarget; 2017 Sep; 8(41):70172-70182. PubMed ID: 29050269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
    J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition.
    Xie R; Wang X; Qi G; Wu Z; Wei R; Li P; Zhang D
    Tumour Biol; 2016 Sep; 37(9):12049-12059. PubMed ID: 27179963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt/β-catenin signaling pathway.
    He P; Xiong G; Guo W; Jiang G; Li Y; Li H
    Oncol Lett; 2020 Oct; 20(4):97. PubMed ID: 32831916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
    Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
    J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA AFAP1-antisense RNA 1 promotes the proliferation, migration and invasion of gastric cancer cells and is associated with poor patient survival.
    Zhao H; Zhang K; Wang T; Cui J; Xi H; Wang Y; Song Y; Zhao X; Wei B; Chen L
    Oncol Lett; 2018 Jun; 15(6):8620-8626. PubMed ID: 29805596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
    Feng Y; Zhang Q; Wang J; Liu P
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway.
    Wu ZJ; Li Y; Wu YZ; Wang Y; Nian WQ; Wang LL; Li LC; Luo HL; Wang DL
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):706-714. PubMed ID: 28272713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis.
    Chen Z; Wu J; Huang W; Peng J; Ye J; Yang L; Yuan Y; Chen C; Zhang C; Cai S; He Y; Wu S; Song W
    Cell Physiol Biochem; 2018; 47(6):2432-2444. PubMed ID: 29991048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis.
    Zhou N; Si Z; Li T; Chen G; Zhang Z; Qi H
    Oncol Lett; 2016 Jul; 12(1):132-138. PubMed ID: 27347113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of LKB1 is associated with epithelial-mesenchymal transition and led to an unfavorable prognosis in gastric cancer.
    Hu M; Zhao T; Liu J; Zou Z; Xu Q; Gong P; Guo H
    Hum Pathol; 2019 Jan; 83():133-139. PubMed ID: 30171989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2.
    Sun D; Wang Y; Wang H; Xin Y
    Cancer Cell Int; 2020; 20():204. PubMed ID: 32514249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRPV4 Overexpression Promotes Metastasis Through Epithelial-Mesenchymal Transition in Gastric Cancer and Correlates with Poor Prognosis.
    Wang H; Zhang B; Wang X; Mao J; Li W; Sun Y; Yuan Y; Ben Q; Hua L; Qian A
    Onco Targets Ther; 2020; 13():8383-8394. PubMed ID: 32943876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.